Study highlights potential of p-tau217 assays in Alzheimer’s clinical trials and diagnosis Post author: Post published:March 14, 2024 Post category:uncategorized The performance of two commercial phospho-tau217 (p-tau217) assays. You Might Also Like Could heparin offer new hope in the fight against dementia? October 9, 2024 Experimental deep brain stimulation offers hope to treat cognitive deficits after traumatic brain injuries December 4, 2023 Reserch sheds light on how mutated PSEN2 accelerates familial Alzheimer’s disease progression December 3, 2024
Experimental deep brain stimulation offers hope to treat cognitive deficits after traumatic brain injuries December 4, 2023
Reserch sheds light on how mutated PSEN2 accelerates familial Alzheimer’s disease progression December 3, 2024